DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nystop (Nystatin Topical Powder) - Published Studies


Nystop Related Published Studies

Well-designed clinical trials related to Nystop (Nystatin Topical)

Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections. [2003]

Perianal candidosis--a comparative study with mupirocin and nystatin. [1999.08]

Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin. [1998]

Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. [1997.06]

A comparative trial of clotrimazole troches and oral nystatin suspension in recipients of renal transplants. Use in prophylaxis of oropharyngeal candidiasis. [1987.11.13]

Well-designed clinical trials possibly related to Nystop (Nystatin Topical)

A randomised controlled trial comparing Triadcortyl with 10% glycerine-ichthammol in the initial treatment of severe acute otitis externa. [2008.08]

The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: a meta-analysis. [2005.10]

Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy. [2004.07]

Antifungal topical therapy in oral chronic candidosis. A comparative study. [2002.07]

The use of otic powder in the treatment of acute external otitis. [2002.05]

Comparative efficacy of two anti-bacterial/anti-inflammatory formulations (Auricularum otic powder and Dex-Otic drops) in the medical treatment of otitis externa. [2002]

Microwave disinfection of dentures for the treatment of oral candidiasis. [2001]

Effectiveness of a topical antifungal regimen for the treatment of oral candidiasis in older, chronically ill, institutionalized, adults. [1995.03]

An alternative to regular dressings for otitis externa and chronic supperative otitis media? [1995.02]

A randomized prospective comparison of two methods of administering topical treatment in otitis externa. [1991.12]

Other research related to Nystop (Nystatin Topical)

Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing. [2011.08]

Potential ototoxicity from triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl) cream. [2005.01]

Retardation of wound healing by silver sulfadiazine is reversed by Aloe vera and nystatin. [2003.12]

[Acute generalized exanthematous pustulosis induced by drugs with low-digestive absorption: acarbose and nystatin] [2003.04]

Does the addition of nystatin to 5% mafenide acetate and genitourinary irrigant solutions interfere with their antimicrobial activity? Assessment by two topical antimicrobial test assay systems. [2001.07]

Nystatin LF (Aronex/Abbott). [2001.04]

Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. [1999.12]

Effect of topical and subcutaneous epinephrine in combination with topical thrombin in blood loss during immediate near-total burn wound excision in pediatric burned patients. [1999.09]

Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury. [1992.02]

Nystatin-perforated patch recordings disclose NMDA-induced outward currents in cultured neocortical neurons. [1990.12.10]

Nystatin allergy. Petrolatum is not the optimal vehicle for patch testing. [1990.01]

The efficacy of nystatin combined with topical microbial agents in the treatment of burn wound sepsis. [1989.11]

Other possibly related research studies

Otomycosis: clinical and mycological study of 97 cases. [2006]

[Use of topical antifungal agents] [2006.05]

Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant. [2006.08]

Survey of topical oral solutions for the treatment of chemo-induced oral mucositis. [2005.12]

Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. [2005.05]

Candida-related denture stomatitis: a pilot study of the efficacy of an amorolfine antifungal varnish. [2005.01]

Pimecrolimus-induced tinea incognito. [2004.11]

The treatment of oropharyngeal candidiasis in HIV-infected patients with oral amphotericin B suspension. [1998.08]

Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. [2003.09]

Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. [2003.08]

Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. [2003.06]

A systematic review of the management of oral candidiasis associated with HIV/AIDS. [2002.12]

Pharmacotherapy of fungal eye infections. [2001.11]

[Antifungal prophylaxis in neutropenic patients] [2001]

Topical treatment for vaginal candidiasis (thrush) in pregnancy. [2001]

Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. [2000.07]

Yeast infection of burns. [2001]

Plasma cell balanitis of Zoon: response to Trimovate cream. [2001.02]

Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis. [2000.05]

Characterization of diaper dermatitis in the United States. [2000.09]

Efficacy of antifungal agents in tissue conditioners in treating candidiasis. [1999.12]

Topical treatment for vaginal candidiasis in pregnancy. [2000]

Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment. [1999.11.01]

The use of a modified Dakin's solution (sodium hypochlorite) in the treatment of Vibrio vulnificus infection. [1999.03]

Incidence of oral complications and application of a preventive protocol in children with acute leukemia. [1998.09]

The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. [1999.04]

Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients. [1999.02]

Options for the management of mucosal candidiasis in patients with AIDS and HIV infection. [1999.01]

Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents. [1998.12]

Antifungal therapy during pregnancy. [1998.11]

Candida-associated denture stomatitis. Aetiology and management: a review. Part 3. Treatment of oral candidosis. [1998.08]

Invasive laryngeal candidiasis: a cause of stridor in the previously irradiated patient. [1998.06]

[Candida infections in infancy and early childhood] [1998.04]

Congenital cutaneous candidiasis associated with respiratory distress and elevation of liver function tests: a case report and review of the literature. [1997.11]

[Oral candidiasis in Sjogren's syndrome: prevalence, clinical features and treatment] [1997.08]

Antifungal activity against allergic fungal sinusitis organisms. [1996.11]

Topical antifungal agents: an update. [1996.10]

Formulation of 'idealized' topical antimicrobial mixtures for use with cultured skin grafts. [1996.09]

Australian Dental Research Fund Trebitsch Scholarship. Efficacy of antifungal prophylaxis in bone marrow transplantation. [1995.08]

Noncytotoxic combinations of topical antimicrobial agents for use with cultured skin substitutes. [1995.06]

Treatment of oropharyngeal candidiasis in HIV-positive patients. [1994.09]

Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole. [1994.02]

Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. [1993.09]

Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata. [1993.04]

Antifungal prophylaxis in immunocompromised hosts. [1993.01]

Topical antifungal agents. [1992.09]

Oral candidosis. Clinical, historical, and therapeutic features of 100 cases. [1992.07]

Superficial fungal infections of the skin. Diagnosis and current treatment recommendations. [1992.05]

Anti-inflammatory action of AGF44, a ganglioside ester derivative. [1992]

The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. [1991.10]

A clinical trial of a topical preparation of miconazole, polymyxin and prednisolone in the treatment of otitis externa in dogs. [1991.06]

Preventing postoperative burn wound aspergillosis. [1991.03]

Pharmacological assay of Cordia verbenacea. III: Oral and topical antiinflammatory activity and gastrotoxicity of a crude leaf extract. [1991.02]

Individualizing treatment of vaginal candidiasis. [1990.09]

Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections. [1990.02]

"Wash leather scrotum" (scrotal dermatitis): a treatable cause of male infertility. [1990.02]

Oral antimicrobial agents--chlorhexidine. [1990]

Eradication of Candida burn wound septicemia in massively burned patients. [1988.02]

Bread-making as a source of vaginal infection with Saccharomyces cerevisiae. Report of a case in a woman and apparent transmission to her partner. [1988.01]

Epidemiology, pathology and clinical features of genital mycoses--1981 status. [1982]

High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione. [2007.03]

In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006). [2007.10.01]

[Treatment of fungal infections of upper respiratory tract and ear] [2007]

Posaconazole for the management of mucosal candidiasis. [2007.06]

An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents. [2008.01]

Ototopical antifungals and otomycosis: a review. [2008.04]

Oral manifestation of cytomegalovirus associated with herpes simplex virus in renal transplant recipient. [2008.06]

Local treatment of vulvovaginal candidosis : general and practical considerations. [2008]

Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. [2008.07]

Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. [2009.10.07]

Support for the role of Candida spp. in extensive caries lesions of children. [2009.01]

Are topical antimicrobials effective against bacteria that are highly resistant to systemic antibiotics? [2009.01]

Sodium iodide associated to salicylic acid in the topical management of chronic oral candidiasis: a randomized trial. [2010.07]

Current concepts in systemic and topical therapy for superficial mycoses. [2010.03.04]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017